Sangui BioTech International, Inc.
Sangui BioTech International focuses on the fluid of life -- blood. The firm specializes in developing oxygen-carrying agents to treat blocked arteries, anemia, or acute blood loss through its Sangui GmbH subsidiary. Also in the pipeline at Sangui is an implantable blood glucose monitor for diabetics. Other products include Pure Moisture, an anti-aging skin care product; HemO2Spray, a spray-on wound treatment; and Chitoskin, a wound dressing that is said to facilitate rapid healing of wounds. Professor Wolfgang K. Barnikol founded the company in Germany in 1995.
Contact Details
Executives
CEO and Director
Thomas Striepe
CFO and Director
Joachim Fleing